Gibson D P, Brauninger R, Shaffi H S, Kerckaert G A, LeBoeuf R A, Isfort R J, Aardema M J
Procter & Gamble Co., Cincinnati, OH 45253-8707, USA.
Mutat Res. 1997 Aug 1;392(1-2):61-70. doi: 10.1016/s0165-1218(97)00045-1.
Sixteen chemicals currently being tested in National Toxicology Program (NTP) carcinogenicity studies were evaluated in the Syrian hamster embryo (SHE) cell in vitro micronucleus assay. Results from these studies were compared to the results from the SHE cell transformation assay for the same chemicals The overall concordance between induction of micronuclei and transformation of SHE cells was 56%, which is far lower that the 93% concordance between these two tests reported previously by Fritzenschaf et al. (1993; Mutation Res. 319, 47-53). The difference between our results appears to be due to differences in the types of chemicals in the two studies. Overall, there is good agreement between the SHE cell micronucleus and transformation assays for mutagenic chemicals, but, as our study highlights, the SHE cell transformation assay has the added utility of detecting nonmutagenic carcinogens. The utility of a multi-endpoint assessment in SHE cells for carcinogen screening is discussed.
在叙利亚仓鼠胚胎(SHE)细胞体外微核试验中,对目前正在国家毒理学计划(NTP)致癌性研究中进行测试的16种化学物质进行了评估。将这些研究的结果与相同化学物质在SHE细胞转化试验中的结果进行了比较。微核诱导与SHE细胞转化之间的总体一致性为56%,这远低于Fritzenschaf等人(1993年;《突变研究》319卷,47 - 53页)之前报道的这两项测试之间93%的一致性。我们结果之间的差异似乎是由于两项研究中化学物质类型的不同。总体而言,SHE细胞微核试验和转化试验在诱变化学物质方面有很好的一致性,但是,正如我们的研究所强调的,SHE细胞转化试验在检测非诱变致癌物方面具有额外的效用。讨论了在SHE细胞中进行多终点评估用于致癌物筛查的效用。